Avidity Biosciences vs Regenxbio
Avidity Biosciences vs Regenxbio, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Avidity Biosciences is on 53/100 and Regenxbio on 55/100.
Where each one leads
Avidity Biosciences
- funding raised: $495M against $180M
Regenxbio
- domain rating: 54/100 against 46/100
- LinkedIn following: 49,536 against 37,705
At a glance
| Measure | Avidity Biosciences | Regenxbio |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases. | Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. |
| Category | Biotech, Drug Discovery, Genomics, Clinical Trials | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2013 | 2008 |
| Headquarters | San Diego, United States | Rockville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Avidity Biosciences | Regenxbio |
|---|---|---|
| Employees | 445 | 396 |
| Total funding | $495M | $180M |
| Latest round | IPO | Funding Round |
| LinkedIn followers | 37,705 | 49,536 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Avidity Biosciences | Regenxbio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 55/100 |
| Traction | 60/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | 22/100 | 24/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Avidity Biosciences | Regenxbio |
|---|---|---|
| Hosting | Self Managed | Not detected |
| Frameworks | Jquery, Bootstrap | Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
Avidity Biosciences vs Regenxbio: common questions
Which is better, Avidity Biosciences or Regenxbio?
On our 0-100 score Regenxbio rates higher (55/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Avidity Biosciences and Regenxbio compare on the numbers?
Avidity Biosciences leads on funding raised ($495M against $180M). Regenxbio leads on domain rating (54/100 against 46/100), LinkedIn following (49,536 against 37,705).
Read the full Avidity Biosciences review and pricing or the Regenxbio review and pricing. You can also browse other Avidity Biosciences alternatives we track.